PNC Financial Services Group
PHAT icon

PNC Financial Services Group’s Phathom Pharmaceuticals PHAT Stock Holding History

PNC Financial Services Group’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9K Buy
1,464
+77
+6% +$879 ﹤0.01% 3885
2026
Q1 		$15.4K Sell
1,387
-34
-2% -$429 ﹤0.01% 3796
2025
Q4 		$23.6K Sell
1,421
-127
-8% -$1.81K ﹤0.01% 3589
2025
Q3 		$18.2K Buy
1,548
+201
+15% +$2.07K ﹤0.01% 3682
2025
Q2 		$12.9K Buy
1,347
+1,037
+335% +$5.74K ﹤0.01% 3763
2025
Q1 		$1.94K Buy
310
+37
+14% +$225 ﹤0.01% 4353
2024
Q4 		$2.22K Hold
273
– – ﹤0.01% 4254
2024
Q3 		$4.94K Buy
273
+122
+81% +$1.71K ﹤0.01% 4043
2024
Q2 		$1.55K Sell
151
-15
-9% -$154 ﹤0.01% 4321
2024
Q1 		$1.76K Buy
166
+31
+23% +$263 ﹤0.01% 4230
2023
Q4 		$1.23K Buy
135
+5
+4% +$43 ﹤0.01% 4280
2023
Q3 		$1.35K Buy
+130
New +$1.78K ﹤0.01% 4320
2020
Q4 		– Sell
-85
Closed -$3K – 4041
2020
Q3 		$3K Hold
85
– – ﹤0.01% 3765
2020
Q2 		$3K Hold
85
– – ﹤0.01% 3727
2020
Q1 		$2K Hold
85
– – ﹤0.01% 3743
2019
Q4 		$3K Buy
+85
New +$2.14K ﹤0.01% 3738

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

PNC Financial Services Group's PHAT Position: Q2 2026 in Review

PNC Financial Services Group increased its Phathom Pharmaceuticals (PHAT) stake by 5.6% in Q2 2026, buying an estimated $879 and bringing the position to 1,464 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3885.

PNC Financial Services Group first reported a position in PHAT in Q4 2019 and has held it in 16 quarters since. The position peaked at $23.6K in Q4 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • PNC Financial Services Group held 1,464 shares of Phathom Pharmaceuticals worth $15.9K as of Q2 2026.
  • PNC Financial Services Group bought 77 Phathom Pharmaceuticals shares in Q2 2026, an estimated $879.
  • Phathom Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3885 holding.
  • PNC Financial Services Group first reported a position in Phathom Pharmaceuticals in Q4 2019 and has held it in 16 quarters since.
  • PNC Financial Services Group's Phathom Pharmaceuticals position peaked at $23.6K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.